Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.008 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.12 | 0.009 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |